Abercrombie & Fitch Reports Q1 EPS Beat, Maintains FY26 Outlook, and Continues $450M Buyback
Summary
Abercrombie & Fitch announced Q1 results with record net sales and an EPS beat, while maintaining its full-year guidance and continuing a substantial share repurchase program.
Key Events
-
Q1 FY26 Financial Results
Reported record first-quarter net sales of $1.1 billion (up 2%), with diluted EPS of $1.47, exceeding the company's outlook. However, comparable sales declined by 1% and operating margin decreased to 8.0% from 9.3% last year.
-
Full-Year FY26 Outlook Maintained
Reaffirmed full-year guidance for net sales growth of 3% to 5% and diluted EPS in the range of $10.20 to $11.00, indicating confidence in its strategic path despite mixed Q1 performance.
-
Significant Share Repurchase Activity
Repurchased 1.2 million shares for approximately $105 million in Q1, representing a 3% reduction in shares outstanding. The company maintains its plan for approximately $450 million in share repurchases for the full fiscal year.
-
Improved Tariff Impact Outlook
Revised the full-year tariff impact outlook, reducing the expected unfavorability from around 70 basis points to around 20 basis points, a positive adjustment for profitability.
Analysis
Abercrombie & Fitch reported record first-quarter net sales and an EPS of $1.47, which exceeded its own outlook. While comparable sales saw a slight decline and operating margin decreased, the company maintained its full-year sales and EPS guidance, signaling stability despite a dynamic global environment and regional weakness in EMEA. The ongoing significant share repurchase program, with $105 million executed in Q1 and $450 million planned for the full year, demonstrates a strong commitment to returning capital to shareholders. Additionally, the company improved its full-year tariff impact outlook, reducing expected unfavorability.
At the time of this filing, ANF was trading at $79.18 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $65.45 to $133.11. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.